Literature DB >> 32503281

Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions.

Maria Joana Catarata1,2,3,4,5, Ricardo Ribeiro1,2,6,7, Maria José Oliveira1,2,4, Carlos Robalo Cordeiro3,8, Rui Medeiros4,5.   

Abstract

The mechanistic involvement of the renin-angiotensin system (RAS) reaches beyond cardiovascular physiopathology. Recent knowledge pinpoints a pleiotropic role for this system, particularly in the lung, and mainly through locally regulated alternative molecules and secondary pathways. Angiotensin peptides play a role in cell proliferation, immunoinflammatory response, hypoxia and angiogenesis, which are critical biological processes in lung cancer. This manuscript reviews the literature supporting a role for the renin-angiotensin system in the lung tumor microenvironment and discusses whether blockade of this pathway in clinical settings may serve as an adjuvant therapy in lung cancer.

Entities:  

Keywords:  hypoxia; lung cancer; renin-angiotensin; tumor microenvironment

Year:  2020        PMID: 32503281     DOI: 10.3390/cancers12061457

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN: 2072-6694            Impact factor:   6.639


  14 in total

Review 1.  The Impact of ACE and ACE2 Gene Polymorphisms in Pulmonary Diseases Including COVID-19.

Authors:  Iphigenia Gintoni; Maria Adamopoulou; Christos Yapijakis
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

2.  Pharmacologic ACE-Inhibition Mitigates Radiation-Induced Pneumonitis by Suppressing ACE-Expressing Lung Myeloid Cells.

Authors:  Guru Prasad Sharma; Brian L Fish; Anne C Frei; Jayashree Narayanan; Tracy Gasperetti; Dana Scholler; Lauren Pierce; Nathan Szalewski; Noah Blue; Meetha Medhora; Heather A Himburg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2022-01-29       Impact factor: 8.013

3.  Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort.

Authors:  Sungji Moon; Hae-Young Lee; Jieun Jang; Sue K Park
Journal:  J Prev Med Public Health       Date:  2020-11-03

4.  Angiotensin converting enzyme inhibitors and risk of lung cancer: A systematic review and meta-analysis.

Authors:  Mohammed Batais; Turky Almigbal; Khalid Alotaibi; Abdulaziz Alodhayani; Abdullah Alkhushail; Abdulrahman Altheaby; Mashhor Alhantoushi; Saad Alsaad; Sultan Al Dalbhi; Yasser Alghamdi
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

5.  Comprehensive landscape of the renin-angiotensin system in Pan-cancer: a potential downstream mediated mechanism of SARS-CoV-2.

Authors:  Yuqing Cui; Fengzhi Chen; Jiayi Gao; Mengxia Lei; Dandan Wang; Xiaoying Jin; Yan Guo; Liying Shan; Xuesong Chen
Journal:  Int J Biol Sci       Date:  2021-09-03       Impact factor: 6.580

6.  AGTR1 Inhibits the Progression of Lung Adenocarcinoma.

Authors:  Lecai Xiong; Yanhong Wei; Xiao Zhou; Peng Dai; Yi Cai; Xuefeng Zhou; Ming Xu; Jinping Zhao; Hexiao Tang
Journal:  Cancer Manag Res       Date:  2021-11-13       Impact factor: 3.989

Review 7.  The Role of the Renin-Angiotensin System in the Cancer Stem Cell Niche.

Authors:  Ethan J Kilmister; Swee T Tan
Journal:  J Histochem Cytochem       Date:  2021-06-24       Impact factor: 2.479

Review 8.  Pathophysiological Roles of Stress-Activated Protein Kinases in Pulmonary Fibrosis.

Authors:  Yoshitoshi Kasuya; Jun-Dal Kim; Masahiko Hatano; Koichiro Tatsumi; Shuichi Matsuda
Journal:  Int J Mol Sci       Date:  2021-06-03       Impact factor: 5.923

Review 9.  RAAS: A Convergent Player in Ischemic Heart Failure and Cancer.

Authors:  Texali C Garcia-Garduño; Jorge R Padilla-Gutierrez; Diego Cambrón-Mora; Yeminia Valle
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

10.  Employing hypoxia characterization to predict tumour immune microenvironment, treatment sensitivity and prognosis in hepatocellular carcinoma.

Authors:  Fanhong Zeng; Yue Zhang; Xu Han; Min Zeng; Yi Gao; Jun Weng
Journal:  Comput Struct Biotechnol J       Date:  2021-04-21       Impact factor: 7.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.